Antibody-based pharmacodelivery of immunomodulators for the treatment of ulcerative colitis
Open access
Author
Date
2016Type
- Doctoral Thesis
ETH Bibliography
yes
Altmetrics
Permanent link
https://doi.org/10.3929/ethz-a-010653850Publication status
publishedExternal links
Search print copy at ETH Library
Publisher
ETH ZürichSubject
HYBRIDPROTEINE + REKOMBINANTE PROTEINE; ANIMAL MODELS IN MEDICINE; INTESTINAL DRUGS + ENTERAL SPASMOLYTICS (PHARMACY); CYTOKINES (IMMUNOLOGY); TARGETED DRUGS (PHARMACOLOGY); DARMMITTEL + ENTERALE SPASMOLYTIKA (PHARMAZIE); ANTIKÖRPERTECHNIKEN (IMMUNOLOGISCHE TECHNIKEN); FIBRONECTIN (GLYCOPROTEINS); ZIELGERICHTETE ARZNEIMITTEL (PHARMAKOLOGIE); FIBRONEKTIN (GLYKOPROTEINE); TIERISCHE MODELLE IN DER MEDIZIN; HYBRID PROTEINS + RECOMBINANT PROTEINS; ANTIBODY TECHNIQUES (IMMUNOLOGICAL TECHNIQUES); ZYTOKINE (IMMUNOLOGIE)Organisational unit
02020 - Dep. Chemie und Angewandte Biowiss. / Dep. of Chemistry and Applied Biosc.03463 - Neri, Dario (ehemalig) / Neri, Dario (former)
More
Show all metadata
ETH Bibliography
yes
Altmetrics